NipentExtra

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameNipentExtra
Drug Alias NamePentoExtraPentostatin - SuperGen
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine deaminase inhibitors
TargetsAdenosine deaminase
Therapy Area/IndicationsLeukemia, Hairy Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstex Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsLeukemia, Hairy Cell

Other Information

ATC CodeN/A
Related LinksN/A